Published in Lung on October 30, 2013
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open (2014) 0.90
Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure. Lung (2016) 0.81
Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure. Bioanalysis (2015) 0.81
Mesothelin (MSLN) methylation and soluble mesothelin-related protein levels in a Chinese asbestos-exposed population. Environ Health Prev Med (2015) 0.76
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives. Respir Res (2017) 0.75
Diagnosis and prognosis-review of biomarkers for mesothelioma. Ann Transl Med (2017) 0.75
Comparison of statistical methods for detection of serum lipid biomarkers for mesothelioma and asbestos exposure. Biomark Med (2017) 0.75
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol (2003) 11.22
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med (2005) 4.11
Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med (2005) 3.55
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg (1999) 3.04
Mesothelin-family proteins and diagnosis of mesothelioma. Lancet (2003) 2.98
Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur Respir J (2012) 2.08
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res (2006) 1.99
Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect (2001) 1.66
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.52
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med (2006) 1.46
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res (2007) 1.45
Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev (1997) 1.43
Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin (2004) 1.28
MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem (2007) 1.27
Combined CA125 and mesothelin levels for the diagnosis of malignant mesothelioma. Chest (2007) 1.20
Pleural mesothelioma in New Caledonia: associations with environmental risk factors. Environ Health Perspect (2010) 1.19
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma. Am J Respir Crit Care Med (2010) 1.14
Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med (2009) 1.04
Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best? Lung Cancer (2011) 0.98
Environmental asbestos exposure and mesothelioma. Curr Opin Pulm Med (2000) 0.96
[Environmental mesotheliomas in northeast Corsica]. Rev Mal Respir (1993) 0.94
Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma. J Thorac Oncol (2011) 0.93
Decreasing prevalence of pleural calcifications among Metsovites with nonoccupational asbestos exposure. Chest (2004) 0.91
Serum levels of soluble mesothelin-related peptides in malignant and nonmalignant asbestos-related pleural disease: relation with past asbestos exposure. Cancer Epidemiol Biomarkers Prev (2009) 0.91
Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev (2011) 0.90
Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med (1998) 0.90
An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Br J Ind Med (1988) 0.89
Asbestos-related pleural disease. Curr Opin Pulm Med (2012) 0.88
Mesothelioma in Cyprus. IARC Sci Publ (1989) 0.88
Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Osteopontin levels in an asbestos-exposed population. Clin Cancer Res (2009) 0.84
Performance of biomarkers SMRP, CA125, and CYFRA 21-1 as potential tumor markers for malignant mesothelioma and lung cancer in a cohort of workers formerly exposed to asbestos. Arch Toxicol (2010) 0.83
High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest (2013) 0.82
Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum. Clin Chem (2009) 0.81
Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics. Cytokine (2013) 0.79
Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med (2013) 0.78
The assessment of the malignant mesothelioma cases and environmental asbestos exposure in Sivas province, Turkey. Environ Geochem Health (2013) 0.77
The continual search for ideal biomarkers for mesothelioma: the hurdles. J Thorac Dis (2013) 0.76
Impact of renal failure on the tumor markers of mesothelioma, N-ERC/mesothelin and osteopontin. Anticancer Res (2011) 0.76
Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. Turk J Gastroenterol (2009) 1.56
Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res (2011) 1.03
MR spectroscopy features of brain in patients with mild and severe obstructive sleep apnea syndrome. Clin Imaging (2013) 0.87
Community-acquired Burkholderia cepacia pneumonia: a report of two immunocompetent patients. Tuberk Toraks (2011) 0.86
Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure. Med Sci Monit (2012) 0.85
Environmental exposure to asbestos: from geology to mesothelioma. Curr Opin Pulm Med (2014) 0.84
[The frequency and properties of REM related obstructive sleep apnea among the patients with mild related obstructive sleep apnea]. Tuberk Toraks (2013) 0.82
High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest (2013) 0.82
The effect of sleep apnea syndrome on the development of diabetic nephropathy in patients with type 2 diabetes. Diabetes Res Clin Pract (2012) 0.82
COPD: an underdiagnosed disease at hospital environment. Wien Klin Wochenschr (2013) 0.80
Oxidative stress status in patients with acute urticaria. Cutan Ocul Toxicol (2013) 0.78
Is living close to ophiolites related to asbestos related diseases? Cross-sectional study. Respir Med (2013) 0.78
A cross sectional observational study on the influence of chronic obstructive pulmonary disease on activities of daily living: the COPD-Life study. Tuberk Toraks (2012) 0.78
Gradual detorsion of torsioned rat testis attenuates ischemia reperfusion injury. J Pediatr Surg (2008) 0.78
Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion. Mol Vis (2013) 0.77
A comparison of the efficacy of 5-fluorouracil/triamcinolone, carnitine and dexamethasone therapy on wound healing in tracheal injury: potential for preventing tracheal stenosis? Eur Arch Otorhinolaryngol (2011) 0.77
Association of MMP2-1306C/T and TIMP2G-418C polymorphisms in retinal vein occlusion. Exp Eye Res (2013) 0.77
Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion. Clin Experiment Ophthalmol (2012) 0.77
Absolute blood eosinophil count and 1-year mortality risk following hospitalization with acute heart failure. Eur J Emerg Med (2012) 0.77
Analysis of manganese superoxide dismutase (MnSOD Ala-9Val) and glutathione peroxidase (GPx1 Pro 198 Leu) gene polymorphisms in psoriasis. Arch Dermatol Res (2013) 0.76
Ultrasound guided fine-needle aspiration biopsy of metastases in nonpalpable supraclavicular lymph nodes in lung cancer patients. Multidiscip Respir Med (2011) 0.75
[Thoracic findings in neurofibromatosis]. Tuberk Toraks (2006) 0.75
Serum levels of gamma-glutamyl transferase are associated with cardiovascular disease in obstructive sleep apnea syndrome. Ann Saudi Med (2014) 0.75
[Churg-Strauss syndrome (two case reports)]. Tuberk Toraks (2005) 0.75
[Semirigid thoracoscopy in the diagnosis of pleural effusion: first four cases in Turkey]. Tuberk Toraks (2011) 0.75
Which Biomarker is most Effective to Determine Severity of Acute Head Trauma in the Experimental Animal Head Trauma Model? Turk Neurosurg (2016) 0.75
VKORC1 C1173T and VKORC1 G-1639A gene polymorphisms in Turkish Behçet's patients with ocular and non-ocular involvement. Ophthalmic Genet (2013) 0.75
Oxidative stress status in patients with melasma. Cutan Ocul Toxicol (2013) 0.75
Pott abscess mimicking aortic aneurysm in chest X-ray. Braz J Infect Dis (2013) 0.75